Literature DB >> 23934309

The urgent need for clear and accurate information on the polymyxins.

Roger L Nation1, Jian Li, John D Turnidge.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23934309     DOI： 10.1093/cid/cit522

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Mucin Binding Reduces Colistin Antimicrobial Activity.

Authors:  Johnny X Huang; Mark A T Blaskovich; Ruby Pelingon; Soumya Ramu; Angela Kavanagh; Alysha G Elliott; Mark S Butler; A Bruce Montgomery; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.

Authors:  Ilias Karaiskos; Lena E Friberg; Konstantinos Pontikis; Konstantinos Ioannidis; Vasiliki Tsagkari; Lamprini Galani; Eirini Kostakou; Fotini Baziaka; Charalambos Paskalis; Antonia Koutsoukou; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

4.  Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy.

Authors:  Nayara Helisandra Fedrigo; Danielle Rosani Shinohara; Josmar Mazucheli; Sheila Alexandra Belini Nishiyama; Floristher Elaine Carrara-Marroni; Frederico Severino Martins; Peijuan Zhu; Mingming Yu; Sherwin Kenneth B Sy; Maria Cristina Bronharo Tognim
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

5.  International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Authors:  Brian T Tsuji; Jason M Pogue; Alexandre P Zavascki; Mical Paul; George L Daikos; Alan Forrest; Daniele R Giacobbe; Claudio Viscoli; Helen Giamarellou; Ilias Karaiskos; Donald Kaye; Johan W Mouton; Vincent H Tam; Visanu Thamlikitkul; Richard G Wunderink; Jian Li; Roger L Nation; Keith S Kaye
Journal:  Pharmacotherapy       Date:  2019-01       Impact factor: 6.251

Review 6.  Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.

Authors:  Ilias Karaiskos; Helen Giamarellou
Journal:  Expert Opin Pharmacother       Date:  2014-04-28       Impact factor: 3.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.